Custom cancer treatment trial aims to match therapy to patient risk
NCT ID NCT07045168
Summary
This study is testing whether personalized treatment plans based on a patient's specific genetic risk factors can better control multiple myeloma, a blood cancer. Researchers will assign different treatment combinations to 200 newly diagnosed patients depending on whether they have high or low genetic risk. The main goal is to see if this personalized approach helps more patients achieve and maintain deep remission with minimal detectable cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Hospital of Jilin University
Changchun, Jilin, 130021, China
Conditions
Explore the condition pages connected to this study.